Published in Curr Opin Lipidol on April 01, 2010
Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol (2003) 3.35
Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. J Exp Med (2009) 2.12
Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science (2007) 2.06
Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol (2005) 1.84
Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol (2012) 1.61
Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe. Arterioscler Thromb Vasc Biol (2003) 1.50
Endogenous ApoE expression modulates adipocyte triglyceride content and turnover. Diabetes (2006) 1.47
Dexamethasone promotes tolerance in vivo by enriching CD11clo CD40lo tolerogenic macrophages. Eur J Immunol (2012) 1.45
Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties. J Lipid Res (2008) 1.39
Paraoxonase, a cardioprotective enzyme: continuing issues. Curr Opin Lipidol (2004) 1.29
Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall. J Lipid Res (2008) 1.18
Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. J Am Coll Cardiol (2011) 1.16
An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide. J Lipid Res (2009) 1.16
Thematic review series: the immune system and atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis. J Lipid Res (2005) 1.14
Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a). J Biol Chem (2003) 1.13
Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis. Am J Pathol (2007) 1.09
Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response. J Lipid Res (2003) 1.09
Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action. Curr Opin Lipidol (2009) 1.04
Discovery, characterization, and significance of the cytochrome P450 omega-hydroxylase pathway of vitamin E catabolism. Ann N Y Acad Sci (2004) 1.03
Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis. J Inflamm Res (2011) 1.00
4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. FASEB J (2010) 0.99
Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice. J Pharmacol Exp Ther (2008) 0.99
Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro. J Lipid Res (2003) 0.99
Self-assembly of HEK cell-secreted ApoE particles resembles ApoE enrichment of lipoproteins as a ligand for the LDL receptor-related protein. Biochemistry (2006) 0.99
Both apolipoprotein E and immune deficiency exacerbate neointimal hyperplasia after vascular injury in mice. Arterioscler Thromb Vasc Biol (2002) 0.98
Engineering mouse apolipoprotein A-I into a monomeric, active protein useful for structural determination. Biochemistry (2005) 0.97
VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice. J Lipid Res (2008) 0.97
Long-chain carboxychromanols are the major metabolites of tocopherols and tocotrienols in A549 lung epithelial cells but not HepG2 cells. J Nutr (2005) 0.97
Vitamin D receptor signaling inhibits atherosclerosis in mice. Mol Endocrinol (2012) 0.97
Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317. Atherosclerosis (2008) 0.95
Biological properties of apolipoprotein a-I mimetic peptides. Curr Atheroscler Rep (2010) 0.95
Nutrition and cardiovascular disease. Arterioscler Thromb Vasc Biol (2007) 0.93
Helix-turn-helix peptides that form alpha-helical fibrils: turn sequences drive fibril structure. Biochemistry (2005) 0.93
Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges. Biochem J (2002) 0.89
The specific amino acid sequence between helices 7 and 8 influences the binding specificity of human apolipoprotein A-I for high density lipoprotein (HDL) subclasses: a potential for HDL preferential generation. J Biol Chem (2008) 0.88
The immune system and murine atherosclerosis. Curr Drug Targets (2007) 0.88
Arginine/arginase NO NO NO. Arterioscler Thromb Vasc Biol (2006) 0.85
Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift. Biochim Biophys Acta (2011) 0.84
Differential effects of activation of liver X receptor on plasma lipid homeostasis in wild-type and lipoprotein clearance-deficient mice. Atherosclerosis (2009) 0.84
Apolipoprotein A-I alpha -helices 7 and 8 modulate high density lipoprotein subclass distribution. J Biol Chem (2001) 0.84
Site-specific influence of polyunsaturated fatty acids on atherosclerosis in immune incompetent LDL receptor deficient mice. Atherosclerosis (2005) 0.84
Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice. J Lipid Res (2004) 0.83
Import of yeast mitochondrial transcription factor (Mtf1p) via a nonconventional pathway. J Biol Chem (2002) 0.83
Regulation of plasma cholesterol esterification by sphingomyelin: effect of physiological variations of plasma sphingomyelin on lecithin-cholesterol acyltransferase activity. Biochim Biophys Acta (2012) 0.83
Increased levels of invariant natural killer T lymphocytes worsen metabolic abnormalities and atherosclerosis in obese mice. J Lipid Res (2013) 0.83
Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background. Arterioscler Thromb Vasc Biol (2013) 0.83
IL-22 is induced by S100/calgranulin and impairs cholesterol efflux in macrophages by downregulating ABCG1. J Lipid Res (2013) 0.82
ApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout mice. J Lipid Res (2012) 0.82
Requirement of different mitochondrial targeting sequences of the yeast mitochondrial transcription factor Mtf1p when synthesized in alternative translation systems. Biochem J (2004) 0.82
Thematic review series: the immune system and atherogenesis. Bridging the innate and adaptive immune systems. J Lipid Res (2005) 0.81
A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice. Br J Pharmacol (2011) 0.80
Lipoproteins produced by ApoE-/- astrocytes infected with adenovirus expressing human ApoE. J Neurochem (2003) 0.80
Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein. J Lipid Res (2012) 0.80
ApoA-I mimetics: tomatoes to the rescue. J Lipid Res (2013) 0.80
LIGHT/TNFSR14 can regulate hepatic lipase expression by hepatocytes independent of T cells and Kupffer cells. PLoS One (2013) 0.79
The structure/function of apoprotein A-I mimetic peptides: an update. Curr Opin Endocrinol Diabetes Obes (2014) 0.79
High-density lipoprotein function in regulating insulin secretion: possible relevance to metabolic syndrome. Arterioscler Thromb Vasc Biol (2010) 0.78
SAA, HDL biogenesis, and inflammation. J Lipid Res (2008) 0.78
Chemical colloids versus biological colloids: a comparative study for the elucidation of the mechanism of protein fiber formation. Biochemistry (2005) 0.77
Cubbing in proapolipoprotein maturation. J Lipid Res (2011) 0.76
Differing rates of cholesterol absorption among inbred mouse strains yield differing levels of HDL-cholesterol. J Lipid Res (2013) 0.76
Do natural killer cells participate in a killer vascular disease? Arterioscler Thromb Vasc Biol (2002) 0.76
Myeloperoxidase-mediated dysfunctional high-density lipoprotein. Arterioscler Thromb Vasc Biol (2014) 0.76
Differential metabolism of apolipoprotein E isoproteins. J Lab Clin Med (2002) 0.76
Atherosclerosis: beyond cholesterol. Curr Opin Lipidol (2011) 0.75
The ABC transporters and the thickening cholesterol plot. Curr Opin Lipidol (2011) 0.75